In Alzheimer research, expression analysis revealed that BECN1 mRNA is reduced in AD brain tissue [59,234], and BECN1 protein levels are significantly lower in the cortex of AD patients compared with age-matched controls [59]. This evidence concerns the gene BECN1 and Alzheimer disease.